Other cytokines such as IL-22, IL-11, and IL-6 have been implicated in enhancing stem cell phenotypes in cancer, and because these cells are less proliferative and less metabolically active, they thus become less sensitive to many forms of chemo- and radiotherapy. This evidence concerns the gene IL6 and cancer.